Pre-specified interim analysis of GALAHAD: A phase II study of niraparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and biallelic DNA-repair gene defects (DRD) Meeting Abstract
| Authors: | Smith, M. R.; Sandhu, S. K.; Kelly, W. K.; Scher, H. I.; Efstathiou, E.; Lara, P. N.; Yu, E. Y.; George, D. J.; Chi, K. N.; Saad, F.; Summa, J.; Freedman, J. M.; Mason, G. E.; Zhu, E.; Ricci, D.; Simon, J. S.; Cheng, S.; Fizazi, K. |
| Abstract Title: | Pre-specified interim analysis of GALAHAD: A phase II study of niraparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and biallelic DNA-repair gene defects (DRD) |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz394.043 |
| Language: | English |
| ACCESSION: | WOS:000491295500174 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz394.043 |
| Notes: | Meeting Abstract: LBA50 -- Appears on pages v884-v885 of the abstract book -- Source: Wos |
